Society values both the appropriate use of new technological and management innovations and the maintenance of a strong personal and therapeutic relationship between patients and physicians. The medical-home model may be able to accomplish both.
A major contributor to the lack of medicines in developing countries is an intellectual property regime that allows proprietary drug companies with intellectual property monopolies to charge high prices and maximize profit.
Undocumented patients in the United States with end-stage renal disease receive “compassionate” dialysis. Such patients oscillate between being marginally well and “ill enough” to receive dialysis while clinicians wrestle with complicity in a system that both offers and withholds life-saving therapy.
AMA J Ethics. 2018;20(8):E778-779. doi:
10.1001/amajethics.2018.778.
Amy Scharf(理学硕士), Louis Voigt(医学博士), Santosha Vardhana(医学博士、哲学博士), Konstantina Matsoukas(图书情报硕士), Lisa M. Wall(哲学博士、注册护士、临床护理专家、高级肿瘤临床护理专家、已获认证的医疗保健伦理顾问), Maria Arevalo(注册护士、肿瘤专科护士), and Lisa C. Diamond(医学博士、公共卫生硕士)
AMA J Ethics. 2021;E97-108. doi:
10.1001/amajethics.2021.97.